(Q71784126)

English

Feasibility and compliance of epirubicin plus ambulatory continuous infusion ifosfamide at escalating doses in advanced soft tissue sarcomas: a phase I study

scientific article published on 01 January 1995

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7577092%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

Feasibility and compliance of epirubicin plus ambulatory continuous infusion ifosfamide at escalating doses in advanced soft tissue sarcomas: a phase I study (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7577092%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

1 reference

based on heuristic

inferred from title

Raffaella Palumbo

1

object named as

R. Palumbo

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7577092

19 May 2024

author name string

S. Toma

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7577092

19 May 2024

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7577092

19 May 2024

publication date

1 January 1995

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7577092%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

full work available at URL

https://api.elsevier.com/content/article/PII:0959804995003149?httpAccept=text/xml

1 reference

10.1016/0959-8049(95)00314-9

https://api.crossref.org/works/10.1016/0959-8049(95)00314-9

19 May 2024

https://api.elsevier.com/content/article/PII:0959804995003149?httpAccept=text/plain

1 reference

10.1016/0959-8049(95)00314-9

https://api.crossref.org/works/10.1016/0959-8049(95)00314-9

19 May 2024

European Journal of Cancer

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7577092%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

31A

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7577092%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7577092%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

1552-1553

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7577092%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

A comparison of adriamycin versus vincristine and adriamycin, and cyclophosphamide versus vincristine, actinomycin-D, and cyclophosphamide for advanced sarcoma

1

1 reference

10.1016/0959-8049(95)00314-9

https://api.crossref.org/works/10.1016/0959-8049(95)00314-9

19 May 2024

Cyvadic in advanced soft tissue sarcoma: A randomized study comparing two schedules: A study of the EORTC soft tissue and bone sarcoma group

2

1 reference

10.1016/0959-8049(95)00314-9

https://api.crossref.org/works/10.1016/0959-8049(95)00314-9

19 May 2024

Prediction of ifosfamide/mesna associated encephalopathy

7

1 reference

10.1016/0959-8049(95)00314-9

https://api.crossref.org/works/10.1016/0959-8049(95)00314-9

19 May 2024

Ifosfamide encephalopathy: a reappraisal

8

1 reference

10.1016/0959-8049(95)00314-9

https://api.crossref.org/works/10.1016/0959-8049(95)00314-9

19 May 2024

Ambulatory 4-day continuous-infusion schedule of high-dose ifosfamide with mesna uroprotection and granulocyte colony-stimulating factor in advanced solid tumours: a phase I study

10

1 reference

10.1016/0959-8049(95)00314-9

https://api.crossref.org/works/10.1016/0959-8049(95)00314-9

19 May 2024

Identifiers

10.1016/0959-8049(95)00314-9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7577092%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7577092%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q71784126&oldid=2158626530"